Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
54.10    0.20 (0.37%)
Bid:
54.10
Ask:
54.60
Spread: 0.50 (0.924%)
Market Cap: £342.43m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Director/PDMR Shareholding

28 Nov 2025 12:36

RNS Number : 4879J
Marston's PLC
28 November 2025
 

28 November 2025

 

Notification of interests of directors and persons discharging managerial responsibilities

Marston's PLC (the "Company") announces that on 27 November 2025, Stephen Hopson, the Company's Chief Financial Officer, was granted awards over ordinary shares in the Company under the Company's Long Term Incentive Plan (the "Plan"), as set out below (the "Buyout LTIP Awards").

 

The Buyout LTIP Awards were awarded to compensate Mr Hopson for three awards over shares in his former employer, Topps Tiles plc ("Topps Tiles"), which were forfeited on leaving Topps Tiles. The Buyout LTIP Awards are in the form of nil-cost options.

 

 

Number of Company shares

Date option will normally be released*

2022 Buyout Nil-Cost Option

444,812

15 December 2027

2023 Buyout Nil-Cost Option

408,887

13 December 2028

2024 Buyout Nil-Cost Option

509,061

1 December 2029**

 

*subject to the extent the performance conditions applicable to the award are met

** dependent on the end of the closed period connected to the preliminary results announcement, following the end of a Holding Period of two years starting at the end of the Performance Period.

 

The Buyout LTIP Awards have been structured in accordance with the principle set out in the Company's approved Remuneration Policy that they should be on a broadly like-for-like basis. Further details will be contained within the Directors' Remuneration Report in the 2025 Annual Report & Accounts.

 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the UK Market Abuse Regulation.

 

Enquiries:

Bethan Raybould, General Counsel & Company Secretary, Marston's PLC, +44 (0) 1902 907250

 

 

 

 

Notification of Dealing Form

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Stephen Hopson

 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Financial Officer)

 

b)

Initial notification/ amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 7.375 pence each

 

 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of awards under the Marston's PLC Long Term Incentive Plan in the form of three nil-cost options.

 

c)

Price(s) and volumes(s)

 

Exercise Price

Volume

2022 Buyout Nil-Cost Option: N/A

444,812

2023 Buyout Nil-Cost Option: N/A

408,887

2024 Buyout Nil-cost option: N/A

509,061

d)

Aggregated information

- Aggregate volume

 

- Price

 

 

1,362,760

 

N/A

e)

Date of the transaction

2025-11-27

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAAFPADLSFFA
Date   Source Headline
17th Dec 20244:22 pmRNSAnnual Financial Report
12th Dec 20242:59 pmRNSDirector/PDMR Shareholding
6th Dec 20249:51 amRNSDirector/PDMR Shareholding
3rd Dec 20247:00 amRNSPRELIMINARY RESULTS
16th Oct 20247:00 amRNSCapital Markets Day
9th Oct 20247:00 amRNSTrading update for the 52 weeks to 28 Sep 2024
23rd Sep 20248:58 amRNSHolding(s) in Company
2nd Sep 20243:55 pmRNSHolding(s) in Company
5th Aug 20243:19 pmRNSDirector/PDMR Shareholding
1st Aug 202412:09 pmRNSTotal Voting Rights
31st Jul 202410:41 amRNSCompletion of disposal of 40% stake in Brewing JV
30th Jul 202411:18 amRNSDirector/PDMR Shareholding
25th Jul 20242:50 pmRNSDirector/PDMR Shareholding
24th Jul 20247:00 amRNSTrading Update for the 42 weeks to 20 July 2024
10th Jul 20248:40 amRNSBlock listing Interim Review
8th Jul 20247:00 amRNSDisposal of 40% Stake in Brewing JV
4th Jul 20247:00 amRNSChair Appointment
14th Jun 20244:07 pmRNSHolding(s) in Company
14th May 20247:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 30 MARCH 2024
13th May 20243:42 pmRNSHolding(s) in Company
28th Mar 20242:50 pmRNSDirector/PDMR Shareholding
15th Mar 202410:15 amRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSSuccession plan to appoint new Chair of the Board
7th Mar 202410:03 amRNSDirector Declaration
6th Mar 20248:35 amRNSDirector/PDMR Shareholding
5th Mar 20244:24 pmRNSDirector/PDMR Shareholding
1st Mar 202412:58 pmRNSTotal Voting Rights
9th Feb 20248:40 amRNSHolding(s) in Company
7th Feb 20244:08 pmRNSHolding(s) in Company
2nd Feb 202411:14 amRNSDirector/PDMR Shareholding
1st Feb 20244:26 pmRNSHolding(s) in Company
31st Jan 20241:52 pmRNSHolding(s) in Company
23rd Jan 20241:30 pmRNSResult of AGM
23rd Jan 20247:00 amRNSTrading for the 16-week period to 20 January 2024
9th Jan 20241:57 pmRNSBlock listing Interim Review
20th Dec 20234:16 pmRNSAnnual Financial Report
5th Dec 20237:00 amRNSPRELIMINARY RESULTS
1st Dec 20232:30 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSDirectorate Change
22nd Nov 20232:02 pmRNSHolding(s) in Company
17th Nov 20237:00 amRNSMarston’s PLC appoints Justin Platt as new CEO
11th Oct 20237:00 amRNSTrading update for the 52 weeks to 30 Sep 2023
15th Aug 20233:36 pmRNSHolding(s) in Company
1st Aug 20239:30 amRNSHolding(s) in Company
26th Jul 20234:29 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSTrading update for the 42 weeks to 22 July 2023
10th Jul 20233:21 pmRNSBlock listing Interim Review
4th Jul 20232:18 pmRNSNotification of Trading Update Date
29th Jun 202310:26 amRNSDirector/PDMR Shareholding
28th Jun 20235:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.